• 15 Jun 20

Immupharma chairman 'delighted' with first significant investment from specialist US funds

Immupharma chairman 'delighted' with first significant investment from specialist US funds

ImmuPharma plc | IMM | 2.7 0.08 0.0%

    • 214 views

 

ImmuPharma PLC's (LON:IMM) Tim McCarthy speaks to Proactive London's Andrew Scott following the news of new funding through two specialist US healthcare investors. Up to US$6.3mln is being invested into IMM from an issue of unsecured convertible securities and associated options to L1 Capital Global Opportunities Master Fund and Lind Global Macro Fund.

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

2025.04.22 Small Cap Snapshot_19.mp4

Companies: ImmuPharma plc

ImmuPharma's Tim McCarthy details Lupuzor licensing deal with Avion Pharmaceuticals

Companies: ImmuPharma plc

ImmuPharma, Arecor, Creo Medical, Anglo Asian Mining, Kodal Minerals - Small Cap Snapshot

Companies: ImmuPharma plc

Investor Update: ImmuPharma lands licensing deal for Lupuzor

Companies: ImmuPharma plc

ImmuPharma, Georgina Energy, Arrow Exploration - Small Cap Snapshot

Companies: ImmuPharma plc

ImmuPharma present product development portfolio and corporate structure overhaul

Companies: ImmuPharma plc

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top